In a pair of identical randomized trials, an old antibiotic in a novel nebulized formulation showed mixed results on benefits for patients with bronchiectasis and Pseudomonas aeruginosa infections, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results